US 10472366
Glucuronide prodrugs of tofacitinib
granted A61PA61P1/00A61P1/02
Quick answer
US patent 10472366 (Glucuronide prodrugs of tofacitinib) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P29/00